Showing results (1-10 of 238) with videos related to
Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2014
Quality control of assembly-defective U1 snRNAs by decapping and 5'-to-3' exonucleolytic digestionSiddharth Shukla, Roy ParkerMolecular and Cellular Biology|August 2, 2017
PARN Modulates Y RNA Stability and Its 3'-End FormationSiddharth Shukla, Roy ParkerTrends in Molecular Medicine|June 7, 2016
Hypo- and Hyper-Assembly Diseases of RNA-Protein ComplexesSiddharth Shukla, Roy ParkerScientific Reports|March 31, 2023
Identification of PARN nuclease activity inhibitors by computational-based docking and high-throughput screeningThao Ngoc Huynh, Siddharth Shukla, Philip Reigan, et al.Cell Reports|April 16, 2025
DM1 repeat-expanded RNAs confer RNA toxicity as individual nuclear-retained RNAsJohn Paul Tsu Ouyang, Siddharth Shukla, Mona Bensalah, et al.Molecular Cell|February 17, 2019
The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 RegulationSiddharth Shukla, Glen A Bjerke, Denise Muhlrad, et al.Nature Structural & Molecular Biology|March 8, 2016
Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defectsSiddharth Shukla, Jens C Schmidt, Katherine C Goldfarb, et al.Blood Advances|June 20, 2020
Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenitaSiddharth Shukla, Ho-Chang Jeong, Christopher M Sturgeon, et al.Science (New York, N.Y.)|March 2, 2023
USB1 is a miRNA deadenylase that regulates hematopoietic developmentHo-Chang Jeong, Siddharth Shukla, Wilson Chun Fok, et al.Blood|February 8, 2019
Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenitaWilson Chun Fok, Siddharth Shukla, Alexandre Teixeira Vessoni, et al.Pageof 24